[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "(650) 407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.42, "open": 7.5, "dayLow": 7.5, "dayHigh": 7.7, "regularMarketPreviousClose": 7.42, "regularMarketOpen": 7.5, "regularMarketDayLow": 7.5, "regularMarketDayHigh": 7.7, "payoutRatio": 0.0, "beta": 0.504, "volume": 35985, "regularMarketVolume": 35985, "averageVolume": 1121380, "averageVolume10days": 78200, "averageDailyVolume10Day": 78200, "bid": 5.45, "ask": 9.68, "bidSize": 2, "askSize": 2, "marketCap": 4763006, "fiftyTwoWeekLow": 6.71, "fiftyTwoWeekHigh": 896.0, "fiftyDayAverage": 9.49836, "twoHundredDayAverage": 87.36819, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1517321, "forwardPE": -2.0486486, "profitMargins": 0.0, "floatShares": 317536, "sharesOutstanding": 628365, "sharesShort": 16267, "sharesShortPriorMonth": 38004, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0315, "heldPercentInsiders": 0.08282, "heldPercentInstitutions": 0.47526002, "shortRatio": 0.0, "shortPercentOfFloat": 0.0271, "impliedSharesOutstanding": 628365, "bookValue": -10.666, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -14243726, "trailingEps": -506.74, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.093, "52WeekChange": -0.9792896, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 7.58, "targetHighPrice": 60.0, "targetLowPrice": 30.0, "targetMeanPrice": 45.0, "targetMedianPrice": 45.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 5203537, "totalCashPerShare": 13.477, "ebitda": -16351915, "totalDebt": 1366585, "quickRatio": 0.662, "currentRatio": 0.734, "returnOnAssets": -1.22863, "freeCashflow": -11192384, "operatingCashflow": -12281578, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "corporateActions": [], "postMarketTime": 1753486819, "regularMarketTime": 1753473600, "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.156332, "regularMarketPrice": 7.58, "postMarketChangePercent": 3.0343, "postMarketPrice": 7.81, "postMarketChange": 0.23, "regularMarketChange": 0.15999985, "regularMarketDayRange": "7.5 - 7.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1121380, "fiftyTwoWeekLowChange": 0.8699999, "fiftyTwoWeekLowChangePercent": 0.12965721, "fiftyTwoWeekRange": "6.71 - 896.0", "fiftyTwoWeekHighChange": -888.42, "fiftyTwoWeekHighChangePercent": -0.99154013, "fiftyTwoWeekChangePercent": -97.92896, "epsTrailingTwelveMonths": -506.74, "epsCurrentYear": -15.39, "priceEpsCurrentYear": -0.4925276, "fiftyDayAverageChange": -1.9183598, "fiftyDayAverageChangePercent": -0.20196748, "twoHundredDayAverageChange": -79.788185, "twoHundredDayAverageChangePercent": -0.91324073, "priceToBook": -0.7106694, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-07-25", "averageAnalystRating": "1.5 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "marketState": "CLOSED", "cryptoTradeable": false, "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]